Knolens KnolScapes is an AI-powered scenario modeling platform that accelerates drug development and market access decisions through dynamic, real-time pharmaceutical insights. The platform serves as a customizable intelligence framework integrating over 10 specialized analysis modules and 50+ analytical panels for comprehensive pharmaceutical strategy development.
KnolScapes gives pharma teams instant, customizable analytics across therapies, diseases, HEOR/HTA, clinical design, biomarkers, and patient outcomes. Trusted in Boston, Cambridge, and global hubs, it delivers evidence-based insights, automated reports, and real-time market intelligence—eliminating manual data work and reducing strategic guesswork
Knolens KnolQuest is an AI-powered research assistant specifically designed for pharmaceutical and life sciences organizations requiring comprehensive biomedical intelligence. The platform serves as a research and discovery engine for the entire pharmaceutical organization, from clinical development teams to market access professionals.
KnolQuest lets pharma teams query biomedical literature, trials, HTAs, real-world evidence, and competitive data via natural language—delivering customized, fully traceable answers in under 5 minutes. With >95% accuracy and 100% source verification, it powers therapeutic analysis, market access, evidence synthesis, and regulatory submissions with FDA/EMA compliance.
Knolens Edge is a real-time pharmaceutical intelligence platform that extends AI-powered analysis capabilities directly into pharmaceutical professionals' everyday workspaces. The platform brings contextual intelligence to any environment where pharmaceutical decisions are made, from scientific conferences to regulatory meetings.
Knolens Edge gives pharma teams instant intelligence from conferences, KOL meetings, publications, and regulatory sessions—capturing, analyzing, and fact-checking content in seconds. With cross-device access, it delivers real-time insights, evidence verification, and actionable notes, enabling faster, smarter decisions anywhere.
Knolens DataNexus is a comprehensive pharmaceutical data aggregation and validation platform that continuously gathers and organizes critical life sciences information from clinical trial registries, biomedical publications, regulatory filings, press releases, and public pharmaceutical databases.
DataNexus is a pharma-grade intelligence platform with 100% traceability, integrating clinical trials, publications, regulatory filings, competitive intelligence, and real-world evidence. Through a chat-based interface, teams can explore therapeutic trends, test hypotheses, and run deep analyses in real time—driving clinical, regulatory, and market access decisions with validated, compliant data.
Knolens Systematic Literature Review (SLR) is an automated pharmaceutical literature analysis platform that revolutionizes evidence synthesis for regulatory submissions, HEOR analysis, and clinical development planning. The platform addresses the critical need for systematic literature reviews in evidence-based pharmaceutical decision-making.
Knolens SLR automates systematic literature reviews, cutting timelines from 4–6 weeks to under 4 hours with 95%+ accuracy. Covering 500+ variables across clinical, economic, and regulatory domains, it delivers PRISMA-compliant, fully traceable evidence. Pharma teams use it for regulatory submissions, HEOR, clinical planning, and market access strategy worldwide.